Tag: Shares

Top Stock Pick: Why I’d Choose This Over SPDR Gold Shares Today

Summary: 1. The SPDR Gold Trust has performed well, but the iShares Silver Trust may be a better

Expedia’s Strong Revenue Growth Fails to Impress Investors; Shares Dip 3%

Expedia Group exceeded expectations in its latest financial report, with fourth quarter revenue reaching $3.55 billion, a year-over-year

Powering Up: The Potential Surge of NextEra Energy Shares in 2026

Summary: 1. NextEra Energy has seen a modest 11% increase in 2026, hinting at potential future growth. 2.

Major Biotech Fund Offloads $120M Worth of Cogent Biosciences Shares

Summary: Fairmount Funds Management LLC, an insider at Cogent Biosciences, sold 3,500,000 shares for approximately $127.4 million in

Director Sells $1.9 Million Worth of GKOS Shares

Summary: 1. Glaukos Corporation director, Marc Stapley, sold 15,000 shares for $1.9 million. 2. Stapley's transaction history, the

Rising Competition: Cortland Associates’ Shedding of $11.7 Million in JD Shares

Summary: 1. Cortland Associates sold a significant amount of JD.com shares, impacting the fund's position and value. 2.

Boston Premier Wealth Unloads 95,000 LMBS Shares – Should MBS Investors Be Concerned?

Summary: 1. First Trust Low Duration Opportunities ETF focuses on short-term bonds to provide a stable yield for

Analyzing the Investment Potential of UnitedHealth in January: Is It a Good Time to Buy Shares?

Summary: 1. UnitedHealth Group faced challenges in 2025, leading to a decline in stock value. 2. The company

Intellia CEO Unloads $314K in Stock, Maintains Strong Ownership with Over 1 Million Shares

Intellia Therapeutics, a biotech company focusing on CRISPR-based therapies for rare diseases and oncology, recently disclosed a significant

Neumann Advisory’s Decision to Sell Off $23.2 Million Worth of Pony AI Shares: A Closer Look at the Recent SEC Filing

Summary: - Neumann Advisory Hong Kong Ltd sold its entire stake in Pony AI Inc. on January 7,

Dianthus Chief Financial Officer Sells Off 20,000 Shares for Over $900,000 Following Strong Year-End Performance

In a recent derivative transaction on Dec. 4, 2025, CFO Ryan Savitz of Dianthus Therapeutics (NASDAQ:DNTH) sold 20,000

NetScout Systems’ Chief Operating Officer Offloads Shares for $54,460

Summary: NetScout Systems reported a significant insider sale by its Chief Operating Officer. The transaction involved the sale